Serum Magnesium Level as a Biomarker to Predict the Risk of Labor Epidural Anesthesia Associated Fever

doi:10.21203/rs.3.rs-625750/v1

Background: Labor epidural anesthesia-associated fever（LEAF) is the biggest problem for labor epidural anesthesia. This study aimed to evaluate the clinical value of serum magnesium levels to predict the LEAF.

Methods: Finally, overall 528 singleton term-pregnant women who underwent labor epidural anesthesia in Fujian Provincial Maternity and Children's Health Hospital, affiliated hospital of Fujian Medical University from January 2019 to June 2019, were analyzed retrospectively. Using venous blood samples, the serum magnesium level was detected. The relationship between the serum magnesium level and LEAF was interpreted, and the optimal cut-off values of the serum magnesium level to predict LEAF were calculated.

Results: Overall, 65（12.30%）participants had LEAF. And a higher rate of the bulging membrane, gestational hypertension, NICU admission, and the different mode of delivery was significantly associated with LEAF. Also, the serum magnesium level demonstrated higher significantly in LEAF presence than absence (p<0.05). What is more, it indicated that the area under the receiver operating characteristic curve (AUC) for the serum magnesium level was 0.825, and an optimal cut-off of the serum magnesium level was 0.855 mg/dl. Furthermore, it demonstrated that the serum magnesium level had the highest OR (OR= 7.49; 95% CI (4.58-14.35) ). The bulging membrane is an independent risk factor LEAF presence (OR = 1.55; 95% CI (1.01-2.43 ).

Conclusions: Serum magnesium may reduce the incidence of LEAF. Serum magnesium can provide a suitable biomarker to predict LEAF and offer a useful target for LEAF treatment.

Anesthesiology & Pain Medicine

Serum magnesium level

Labor epidural anesthesia associated fever

Inflammation

Risk

Therapy

Childbirth pain is a process of intertwining physical and psychological. Excessive pain will have adverse effects on the mother and fetus. With the advancement of society and the development of anesthesia technology, labor epidural analgesia has been recognized and accepted by more pregnant women. In the United States, it is reported that labor epidural analgesia was used by more than 70% of women undergoing childbirth^[1]. However, relevant research shows that the rate of labor analgesia is less than 10% in China, closely related to the increase in the cesarean section rate ^[2]. Therefore, it is essential to promote labor analgesia vigorously in China, which is beneficial for pregnant women and babies.

At present, the clinically used labor epidural analgesia method is mainly intraspinal block, labor epidural associated, which has the advantages of good analgesic effect and little impact on mother and baby^[3]. Although labor epidural anesthesia is worthy of vigorous clinical promotion, it still faces many practical applications. One of the most significant issues is that the rate of labor epidural-associated fever (LEAF) is significantly higher than that without labor epidural anesthesia. Studies have shown that 26% of delivery women receiving labor epidural anesthesia have LEAF^[4]. Subsequently, many observational studies and prospective studies have also confirmed this clinical phenomenon^[5]. Intrapartum fever may have potential adverse effects on mothers and babies. Parturients who suffer from epidural analgesia-related intrapartum fever are more likely to receive vaginal device-assisted labor and cesarean section^[6]. Intrapartum fever also increases the possibility of infection screening and antibiotic use. In most cases, these obstetric interventions are unnecessary, and there is a suspicion of overtreatment of the parturient^[7]. Besides, a prospective cohort study conducted by Impey et al.^[8] on 4 915 parturients showed that intrapartum fever is closely related to neonatal encephalopathy (OR = 10.8, 95% CI: 4.0-29.3). The outcome model of intrapartum fever related to epidural labor analgesia showed that injection of IL-6 induced non-infectious fever in pregnant mice can lead to fetal neuritis^[9]. Therefore, it is urgent to find an effective method to reduce LEAF.

Understanding LEAF's mechanism can help to adopt safe and effective prevention measures to reduce the fever rate during childbirth. Unfortunately, the exact pathogenesis of LEAF is not yet clear. Initially, LEAF was attributed to infection, but the mothers' placental histological examination and blood culture with LEAF did not reveal microbes. Preoperative prophylactic antibiotics did not reduce the incidence of LEAF. However, parturients receiving labor epidural analgesia have significantly increased expression of IL-6 and other inflammatory factors^[10–13]. Therefore, the etiology of LEAF is most likely a non-infectious inflammatory reaction^[12]. Some clinical studies can support this theory. Kopsky DJ et al. ^[14] reported that the use of dexamethasone could reduce the LEAF. And this effect on the reduction of IL-6 levels caused by dexamethasone.

Additionally, a recent animal study demonstrated that the exogenous IL-6 injections could induce fever in near term pregnant rats^[9]. The expression of inflammatory factors is significantly increased during fever, but fever is also related to the decrease in the release of anti-inflammatory factors such as IL-1 receptor antagonist (IL-1RA)^[15–16]. However, LEAF's pathogenesis is still in the exploratory stage, and there are limited clinical indicators. Therefore, it is meaningful to find newer and more convenient biomarkers to predict LEAF's risk and provide new treatment options for the treatment of LEAF.

Studies have shown that magnesium sulfate has a protective effect on newborns' brains. The use of magnesium sulfate before delivery can reduce cerebral palsy probability in preterm infants^[17–18]. Interestingly, a retrospective cross-sectional study^[19] showed that intrapartum fever incidence with and without magnesium sulfate was 6% and 10.2%, respectively, indicating magnesium sulfate can significantly reduce the incidence of intrapartum fever, but the mechanism is not precise. Further prospective studies are needed to confirm and evaluate the dose-effect relationship between them. In the rat model, magnesium sulfate inhibited the increase in maternal temperature caused by IL-6^[9]. Besides, in a small clinical study, it was found that when magnesium sulfate was injected intravenously, it was observed that pregnant women's central core temperature decreased^[20]. Therefore, magnesium may also have a role in maternal fever reduction. However, there are a few studies about the relationship between the serum magnesium level and LEAF. Here, we investigate whether the serum magnesium level is predictive of LEAF and becomes a potential target for LEAF treatment.

1. Patients and study design

We analyzed 528 participants from the Fujian Provincial Maternity and Children's Health Hospital, affiliated hospital of Fujian Medical University, from January 2019 to July 2019. All populations must meet the following criteria: 1) Singleton head pregnancy; 2)age above 18 years; 3) 28-42 weeks of pregnancy; 4) basal body temperature is less than 37.5℃, no prenatal fever. Patients were excluded if pregnant women with upper respiratory tract infection, urinary tract infection, and postpartum placental umbilical cord pathological examination suggesting placental umbilical cord infection. The study was approved by the Hospital Ethics Committee (FMCH20181003), and all individuals participating in this study provided written informed consent. Detailed data on pregnancy health information and neonatal data were collected from computerized obstetric records, neonatal databases, and handwritten records.

2. Biomarker assessment

Patients’ venous blood samples were obtained after at least 12 h of fasting after admission and stored at –80° C. Serum magnesium level is tested immediately by standardized methods using an automatic blood analyzer (7600- 020; Hitachi, Ltd., Tokyo, Japan) following clinical laboratory guidelines.

3. Maternal LEAF assessment

The primary outcome was LEAF's presence, which was defined as a basal body temperature of ≥37.5˚C (99.5˚F) while getting labor epidural analgesia. Women who had at least one recorded temperature ≥of 37.5˚C (99.5˚F) were considered to have LEAF. As noted previously, participants without an adequate record of intrapartum temperatures were excluded. In an epidural catheter placement, the temperature measurement was defined as being taken within 2 hours before or 1 hour after labor epidural analgesia.

4. Statistical analysis

T-tests analyzed the counting data, and the measurement data were used Chi-square tests. To evaluate the association between the serum magnesium level and leaf, linear by linear analysis was performed. The data were calculated using the IBM SPSS statistical package version 22.0 (IBM Corporation, Armonk, NY, USA). Diagnostic accuracy of serum magnesium level for LEAF was expressed as the area under the receiver operating characteristic (ROC) curve (AUC). The odd's ratios (ORs) with 95% confidence intervals (CIs) were analyzed to estimated different risks. In all statistical tests, the differences were considered statistically significant at P-values<0.05

Patient characteristics

Finally, a total of 528 patients were included in the study period. Demographic and clinical data from the study participants are presented in Table 1. Overall, 65（12.30%）participants had LEAF presence and the mean serum magnesium was 0.76± 0.11 (mg/dl). The mean age was 28.21 ± 4.07 years, and the mean gestational age at delivery was 39.32±1.21 weeks. Furthermore, the mean gravity was 1.54± 0.72 times, and the mean parity was 0.37± 0.56 times, the mean height was 160.74± 4.83 cm, the mean weight was 67.63± 7.82 kg, the mean body mass index (BMI) was 26.24± 2.71 kg/m2. Of the patients, 180（34.10%）had bulging membrane, 89（16.90%）had gestational diabetes mellitus (GDM), 23（4.40%) had gestational hypertension, and 41（7.80%) had a postpartum hemorrhage. Also, 67（12.70%）suffered cesarean delivery, 38（7.20%）needed assisted vaginal delivery, and the rest（80.10%）was vaginal delivery successfully. The mean birth weight was 3327.64±370.12g, and 44（8.30%) of the newborns needed neonatal intensive care unit (NICU).

Table 1

Baseline characteristics of participants in the study.

Characteristic	Number of cases (%) (N=528)
Age (y)	28.21 ± 4.07
Gravity	1.54± 0.72
Parity	0.37± 0.56
Height (cm), mean (SD)	160.74± 4.83
Weight (kg), mean (SD)	67.63± 7.82
BMI (kg/m2 ), mean (SD)	26.24± 2.71
Bulging membrane	180（34.10）
Postpartum hemorrhage	41（7.80）
GDM	89（16.90）
Gestational hypertension	23（4.40）
Mode of delivery
Cesarean delivery	67（12.70）
Vaginal delivery	423（80.10）
Assisted vaginal delivery	38（7.20）
GA at delivery (weeks)	39.32±1.21
Birth weight (g)	3327.64±370.12
NICU admission	44（8.30）
LEAF	65（12.30）
Serum Magnesium (mg/dl)	0.76± 0.11
a Continuous variables are presented as mean ± SD (range) and categorical variables as n (%). Abbreviations: GA, gestational age; SD, standard deviation; GDM, gestational diabetes mellitus，BMI, body mass index; NICU, neonatal intensive care unit; LEAF, labor epidural associated fever.

The associations between risk factors and LEAF

As shown in Table 2, all participants (N=528) were composed of those with LEAF (N=65) or without (N=463). This study revealed that the women with LEAF, versus without, were more likely to present for bulging membrane (43.08% vs. 32.83%) (p=0.013) and had a higher incidence of gestational hypertension (9.23% vs. 3.67%) (p=0.004). Furthermore, the mode of delivery (P=0.032), NICU admission (P=0.002), and the serum magnesium level (P<0.001) were significantly different between the two groups. We realized a significant difference in means of serum magnesium level in two groups (p<0.001, ANOVA test) (Fig. 1A). There were no differences between the two groups when comparing age, gestational age, gravity, parity, height, weight, BMI, GDM, postpartum hemorrhage, and fetus's birth weight during labor.

Table 2

The correlation between clinical Factors and LEAF

Variable	Fever (N=65) n (%)	No fever (N=463) n (%)	P‑value
Maternal age (years)	28.51±5.21	27.89±4.02	0.805
Gravida	1.49±0.77	1.52±0.86	0.786
Parity	0.29±0.55	0.28±0.51	0.945
Height (cm)	160.10±4.98	160.73±4.82	0.328
Weight (kg)	67.37±7.68	67.61±7.91	0.817
BMI (kg/m2 )	26.27±2.62	26.16±2.71	0.749
Bulging membrane	28(43.08%)	152(32.83%)	0.013
Postpartum hemorrhage	5 (7.69%)	36 (7.77%)	0.981
GDM	10(15.38%)	79(17.06%)	0.735
Gestational hypertension	6(9.23%)	17(3.67%)	0.004
Mode of delivery
Cesarean delivery	17(26.16%)	50(10.80%)	0.032
Vaginal delivery	38(58.46%)	385(83.15%)
Assisted vaginal delivery	10(15.38%)	28(6.05%)
GA at delivery (weeks)	39.22±1.24	39.29±1.15	0.643
Birth weight (g)	3320.85±437.83	3328.58±359.97	0.875
NICU admission	15(22.06%)	33(7.13%)	0.002
Serum Magnesium (mg/dl)	0.89±0.16	0.74±0.08	<0.001
The counting data were analysed with t-tests and the measurement data were chi-square tests. Abbreviations: GA, gestational age; GDM, gestational diabetes mellitus，BMI, body mass index; NICU, neonatal intensive care unit;LEAF, labor epidural associated fever.

The serum magnesium level is a predictive factor for the LEAF presence.

ROC analyses of the serum magnesium level were performed (Fig. 1B). We observed that AUC for the serum magnesium level was 0.825. Also, an optimal cut-off of the serum magnesium level was 0.855 mg/dl.

As shown in Table 3, the independent factors associated with the diagnosis of LEAF presence were identified in the multiple logistic regressions. It is demonstrated that the serum magnesium level had the highest OR (OR= 7.49; 95% CI (4.58-14.35) ). The bulging membrane is an independent risk factor LEAF presence (OR = 1.55; 95% CI (1.01-2.43 ).

Table 3

Multiple logistic regression analysis of factors associated with LEAF.

Variable	OR	95% CI	P value
Bulging membrane	1.55	1.01-2.43	0.038
Gestational hypertension	0.83	0.39-1.63	0.453
Mode of delivery	0.69	0.31-1.67	0.698
NICU admission	0.97	0.35-2.10	0.546
Serum Magnesium	7.49	4.58-14.35	<0.001
NICU, neonatal intensive care unit;LEAF, labor epidural associated fever; OR: odds ratio; 95% CI: 95% confifidence interval.

This study indicated that the serum magnesium level showed a significant association with LEAF presence. Hence, our study may provide information with a new and possible biomarker to predict the LEAF presence and offer a potential target for the treatment of LEAF presence.

Childbirth is a complex and highly individualized process. Long-term pain will have adverse effects on pregnant women's physiology and psychology, which will affect the delivery process and the safety of the fetus. In recent years, with the advancement of anesthesiology and the change of people's fertility awareness, more and more pregnant women have begun to adopt necessary analgesic measures to relieve labor pain and improve labor outcomes. However, LEAF presence seriously affects the promotion and application of labor analgesia technology.

In this study, 65(12.30%)participants had LEAF presence, which was lower than that reported in the previous study^[4]. In clinical studies, LEAF incidence varies greatly, ranging from 1.6–46.3%^[21], which may be due to different epidural drug concentrations or dose, infusion mode, and too long epidural sedation. Zhou X et al. ^[22] compared the different amounts with 0.075% ropivacaine and 0.125% ropivacaine combined with a 0.25 µg/ml sufentanil labor epidural analgesia, and the results showed a higher concentration of ropivacaine, the higher body temperature, and serum IL-6 level. Moreover, this study revealed that the mode of delivery (P = 0.032) and NICU admission (P = 0.002)were significantly different between the women with LEAF and without, which was similar to the previous study, Greenwell EA et al. ^[23]found that neonatal conditions including 1 min and 5 min Apgar scores were lower in women with LEAF than women without LEAF, and in women with LEAF, the incidence of fetal distress, intrauterine death, acidosis or hypoxemia, the rates of neonatal asphyxia, convulsions, assisted ventilation or cardiopulmonary resuscitation, oxygen therapy, and transfer to the NICU after delivery are all higher than those women without LEAF.

Currently, the mechanism of fever during childbirth has not been fully revealed. LEAF presence likely has multiple causes. The non-infection response is now the most likely mechanism for triggering LEAF because intrapartum fever has inflammation and cytokine production, but there is no acute infection ^{evidence [24]}. The non-infection response occurs in the absence of pathogenic bacteria and is caused by some endogenous molecules released after tissue injury. These endogenous molecules can act through pattern recognition receptors, such as Toll-like receptors, and ultimately lead to increased secretion of pro-inflammatory factors and fever-inducing cytokines in the body^[25].In many kinds of research ^[10–13] about LEAF presence, the increase of IL-1, IL-6, and cytokines are involved. Therefore, the growth of IL-6 secretion is closely related to the LEAF presence. However, the level of IL-6 in women during pregnancy gradually increases with the increase of gestational age and the progress of labor. It plays a vital role in maintaining normal pregnancy and labor initiation and is closely related to the intensity and frequency of contractions^[26]. Therefore, IL-6 cannot be used as a specific indicator in clinical practice.

As we are known, pregnant women with LEAF presence increase adverse pregnancy outcomes for pregnant women and newborns. In this study, we demonstrated that the women with LEAF, versus those without, were more likely to had a higher incidence of gestational hypertension (9.23% vs. 3.67%) (p = 0.004) and a higher rate of cesarean delivery (p = 0.032), which is similar to previous research^[6]. Therefore, there is an urgent need to clarify the specific pathophysiological mechanism of non-infectious inflammation caused by labor epidural analgesia to solve LEAF presence's possible adverse clinical outcomes. Tian et al. ^[27] proposed that the maternal serum IL-6 level can be reduced to reduce the rate of LEAF presence. Kopsky DJ et al. ^[14] used an intraspinal injection of dexamethasone to observe its effect on fever in delivery patients. The results showed that intraspinal injection of dexamethasone had a significant impact on preventing LEAF presence. However, these research methods have medical deficiencies, so they have not been certified and recommended, and further research is needed.

Furthermore, this study demonstrated that the serum magnesium level showed a significant association with LEAF presence. Magnesium sulfate has antispasmodic, vasodilatory, and direct inhibition of uterine smooth muscle contraction to prevent premature birth, so it is widely used in pregnant women with obstetric pathological pregnancy. The therapeutic dose of magnesium sulfate has no apparent adverse reactions to pregnant women and fetuses^[28]. Clinical studies and animal model studies show that magnesium sulfate can lower body temperature^{[9, 19]}. However, how magnesium sulfate affects body temperature regulation is not entirely known.

Magnesium-induced peripheral vasodilation may be thought to accelerate the drop in core temperature observed in healthy volunteers in research experimental settings^[29]. In a study of 3,713 healthy postmenopausal women^[30], it was found that high-magnesium dietary intake was associated with reduced systemic levels of inflammatory cytokines (such as IL-6). Therefore, magnesium may weaken the systemic inflammatory cascade, thereby decreasing the fever response during delivery.

As we knew, these are a few studies to describe this negative association between the serum magnesium level and LEAF presence. However, there are some limitations to this research. First, the specimen's size was not big enough. For a more accurate evaluation, increasing the sample size may be necessary for future studies. Second, in our research, we did not further study the relationship between the serum magnesium level and maternal and neonatal outcome, which is worth further studying.

In conclusion, our results demonstrate that the high serum magnesium level can decrease LEAF presence. We advocate serum magnesium level as a suitable biomarker to predict LEAF presence. Our products may offer a useful target for the treatment of LEAF presence and promote the further development of labor epidural analgesia.

With the advancement of society and the development of anesthesia technology, labor epidural analgesia has been recognized and accepted by more pregnant women. However, labor epidural anesthesia-associated fever(LEAF) is the biggest problem for labor epidural anesthesia and the exact pathogenesis of LEAF remain poorly understood. So, it is of far-reaching clinical significance for biomarker to distinguish LEAF presence. Based on the aim, this study is to determine the clinical value of serum magnesium levels is predictive of LEAF. This study reveled that serum magnesium levels can be used as a reliable predictor of the LEAF. And serum magnesium levels ≤ 0.855 mg/dl can be used as an reliable predictor of LEAF.

AUC,receiver operating characteristic curve

BMI, body mass index

CI,confidence intervals

GDM, gestational diabetes mellitus

IL-1RA,IL-1 receptor antagonist

LEAF, Labor epidural anesthesia-associated fever

NICU, neonatal intensive care unit

OR, odd's ratio

Ethics approval and consent to participate

The study was approved by the Hospital Ethics Committee (FMCH2017J01232) and complied with Helsinki's Declaration. All individuals participating in this study provided written informed consent.

Consent for publication

All authors approve the article publish.

Availability of data and material

Not applicable.

Competing Interests :

Not applicable.

Funding：

The study was supported by grants from the Fujian Provincial Health Technology Project (grant no. 2019-CX-8). The fund provides a certain amount of research funding for this research

Authors' contributions

Conceptualization:CZW , HLN, CL，LGL

Methodology: CZW, CLH, LGL

Software: CZW, QQJ

Formal Analysis: CZW, CLH

Investigation: CZW, HLN, CL

Data Curation: CZW, HLN, CL, XL，

Writing - original draft: CZW, HLN

Writing - review & editing: CL,LGL

Funding Acquisition: LGL.

all authors have read and approved the manuscript

Acknowledgements:

Not applicable.

Butwick AJ, Bentley J, Wong CA, et al..United States State-Level Variation in the Use of Neuraxial Analgesia During Labor for Pregnant Women. JAMA network open. 2018 Dec 7; 1 (8):e186567–.
Lumbiganon P,Laopaiboon M,Gulmezoglu AM,et al.Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08.Lancet,2010,375(9713): 490–499
Li MJ,Xu Q,Li MY. The mechanism of labor pain and the usual methods of labor analgesia.J Int Obstet Gynecol, 2018,45: 125–129.
Sultan P,David AL,Fernando ï¼²,et al.Inflammation and epidural-related maternal fever: proposed mechanisms.Anesth Analg,2016,122(5): 1546–1553
Sharpe EE, Arendt KW. Epidural Labor Analgesia and Maternal Fever[J]. Clinical Obstetrics & Gynecology, 2017, 60(2):365–374.
Segal S. Labor epidural analgesia and maternal fever. Anesth Analg, 2010, 111(6):1467–1475.
White A, Olson D, Messacar K. A statewide assessment of the association between epidural analgesia, maternal fever, and neonatal antibiotics in Colorado, 2007–2012. Arch Dis Child Fetal Neonatal Ed, 2017, 102(2): F120–F125.
Impey L, Greenwood C, McQuillan K, et al. Fever in Labour and Neonatal Encephalopathy: A Prospective Cohort Study. BJOG: an international journal of obstetrics and gynecology, 2001,108(6): 594–597.
Segal S, Pancaro C, Bonney I, et al. Non-infectious Fever in the Near- Term Pregnant Rat Induces Fetal Brain Inflammation: A Model for the Consequences of Epidural- associated Maternal Fever. Anesth Analg, 2017, 125(6): 2134–2140.
Sharma SK, Rogers BB, Alexander JM, et al. A Randomized Trial of the Effects of Antibiotic Prophylaxis on Epidural- Related Fever in Labor. Anesth Analg, 2014, 118(3):604–610.
Goetzl L, Evans T, Rivers J, et al. Elevated maternal and fetal serum interleukin- 6 levels are associated with epidural fever. Am J Obstet Gynecol, 2002, 187(4):834–838.
Riley LE, Celi AC, Onderdonk AB, et al. Association of Epidural- Related Fever and Non-infectious Inflammation in Term Labor. Obstet Gynecol, 2011, 117(3):588–595.
Mantha VR, Vallejo MC, Vimala R, et al. Maternal and Cord Serum Cytokine Changes with Continuous and Intermittent Labor Epidural Analgesia: A Randomized Study. The Scientific World Journal, 2012, 2012:607938.
Kopsky DJ,Keppel Hesselink JM. Phenytoin cream for the treatment for neuropathic pain: case series. Pharmaceuticals (Basel),2018,11( 2): 53.
Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol, 2015, 15(6):335–349.
Palomo J, Dietrich D, Martin P, et al. The interleukin (IL)- 1 cytokine family- Balance between agonists and antagonists in inflammatory diseases. Cytokine, 2015, 76 (1):25–37.
Chollat C, Sentilhes L, Market S. Protection of brain development by antenatal magnesium sulfate for infants born preterm. Dev Med Child Neurol, 2019, 61(1):25–30.
Burd I, Breen K, Friedman A, et al. Magnesium sulfate reduces inflammation- associated brain injury in fetal mice. Am J Obstet Gynecol, 2010, 202(3):292.
Lange EMS, Segal S, Pancaro C, et al. Association between Intrapartum Magnesium Administration and the Incidence of Maternal Fever: A Retrospective Cross-sectional Study. Anesthesiology, 2017, 127(6):942–952.
Parsons MT, Owens, CA, Spellacy WN. Thermic effects of tocolytic agents: Decreased temperature with magnesium sulfate. Obstet Gynecol 1987; 69:88–90
Sharpe EE, Arendt KW. Epidural Labor Analgesia and Maternal Fever[J]. Clinical Obstetrics & Gynecology, 2017, 60(2):365–374
Zhou X, Li J, Deng S, et al. Ropivacaine at different concentrations on intrapartum fever, IL- 6 and TNF- α in a parturient with epidural labor analgesia. Experimental and therapeutic medicine, 2019,17(3):1631–1636.
Greenwell EA, Wyshak G, Ringer SA, et al. Intrapartum Temperature Elevation, Epidural Use, and Adverse Outcome in Term Infants. PEDIATRICS, 2012, 129(2):e447- e454. D
Del Arroyo AG,Sanchez J,Patel S,et al.ï¼²ole of leucocyte caspase-1 activity in epidural-related maternal fever: a single-center,observational,mechanistic cohort study.Br J Anaesth,2019,122(1): 92–102
Sultan P,David AL,Fernando ï¼²,et al.Inflammation and epidural-related maternal fever: proposed mechanisms. Anesth Analg,2016,122(5): 1546–1553
Mantha VR, Vallejo MC, Vimala R, et al. Maternal and Cord Serum Cytokine Changes with Continuous and Intermittent Labor Epidural Analgesia: A Randomized Study. The Scientific World Journal, 2012, 2012:607938. D
Tian F, Wang K, Hu J, et al. Continuous spinal anesthesia with sufentanil in labor analgesia can induce maternal febrile responses in puerpera. Int J Clin Exp Med, 2013, 6(5): 334–341.
Doyle LW, Crowther CA, Middleton P, et al. Antenatal magnesium sulfate and neurologic outcome in preterm infants: A systematic review. Obstet Gynecol 2009; 113:1327–33
Zweifler RM, Voorhees ME, Mahmood MA, et al. Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. Stroke 2004; 35:2331–4
Chacko SA, Song Y, Nathan L, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33:304–10

No competing interests reported.

Serum Magnesium Level as a Biomarker to Predict the Risk of Labor Epidural Anesthesia Associated Fever

Status:

Version 1

Abstract

Figures

Background

Materials And Methods

1. Patients and study design

2. Biomarker assessment

3. Maternal LEAF assessment

4. Statistical analysis

Result

Patient characteristics

The associations between risk factors and LEAF

The serum magnesium level is a predictive factor for the LEAF presence.

Discussion

Conclusions

Abbreviations

Declarations

Ethics approval and consent to participate

Consent for publication

Availability of data and material

Competing Interests :

Funding：

Authors' contributions

Acknowledgements:

References

Additional Declarations

Status:

Version 1